Daiichinkyo Co (TSE:4568) Marketable Securities : 円577,040 Mil (As of Mar. 2024)

View and export this data going back to 2005. Start your Free Trial

What is Daiichinkyo Co Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Daiichinkyo Co's Marketable Securities for the quarter that ended in Mar. 2024 was 円577,040 Mil.

Daiichinkyo Co's annual Marketable Securities increased from Mar. 2022 (円181,368 Mil) to Mar. 2023 (円383,205 Mil) and increased from Mar. 2023 (円383,205 Mil) to Mar. 2024 (円577,040 Mil).

Daiichinkyo Co Marketable Securities Historical Data

The historical data trend for Daiichinkyo Co's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Daiichinkyo Co Marketable Securities Chart

Daiichinkyo Co Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Marketable Securities

Get a 7-Day Free Trial

466,528.00

444,368.00

181,368.00

383,205.00

577,040.00

Daiichinkyo Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Marketable Securities	Get a 7-Day Free Trial															383,205.00	221,169.00	77,542.00	534,275.00	577,040.00

Daiichinkyo Co Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Daiichinkyo Co (TSE:4568) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Daiichinkyo Co Marketable Securities Related Terms

Thank you for viewing the detailed overview of Daiichinkyo Co's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Daiichinkyo Co (TSE:4568) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Daiichi Sankyo Co Ltd (TSE:4568) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

DSNKY:USA DSKYF:USA D4S:Germany

Address

3-5-1, Nihonbashi-honcho, Chuo-ku, Tokyo, JPN, 103-8426

Website

https://www.daiichisankyo.com

Daiichi Sankyo was established by the merger of Daiichi Pharmaceuticals and Sankyo in 2005. As of 2021, approximately half of revenue comes from its Japan businesses, which will shrink in the future as the company expands its global footprint. Its primary growth driver is its leading platform of antibody drug conjugates. Its three lead ADCs are Enhertu (HER2), Dato-DXd (TROP2), I-DXd (B7-H3), HER3-DXd (HER3), and R-DXd (CDH6). Enhertu entered the clinic in 2015 and received its first U.S approval in December 2019 for third-line late-stage HER2-positive breast cancer. It is also approved for HER2-positive stomach cancers and HER2 mutant non-small cell lung cancer.

Daiichinkyo Co (TSE:4568) Headlines

No Headlines